384
C. T. Brain, S. A. Brunton
LETTER
for 10 minutes. Filtration of the resin and removal of THF in
vacuo provided the oxadiazole 4, which required no further
purification; (b) General procedure under microwave
conditions: A mixture of 3 (0.1 mmol), 2 (5 eq) and 5 (2 eq) in
THF (3 ml) in a screw-top Pyrex tube (16 × 100 mm) fitted
with a PTFE septum was irradiated in a Labwell MW10
microwave apparatus (Personal Chemistry, Uppsala, Sweden)
for 5 × 1min (100 W) with 2 min cooling between each run
(CAUTION: PRESSURE DEVELOPS). After cooling to
room temperature in the microwave cavity, the reaction
mixture was washed with Amberlyst 15 (excess) followed by
filtration of the resin and removal of THF in vacuo to provide
4, which required no further purification. Selected data: 4l,
white solid; mp 98-100 °C; 1H NMR (400 MHz, CDCl3) 8.03
(2 H, dd, J 7.6, 1.2, ArH), 7.50-7.52 (3 H, brm, ArH), 5.15
(0.25 H, brs, Pro-CH), 5.05 (0.75 H, brs, Pro-CH), 3.58-3.67
(2 H, brm, Pro-CH2), 1.94-2.19 (4 H, brm, 2 × Pro-CH2) 1.43
(3 H, s, tBu) 1.25 (6 H, s, tBu); m/z (ES+) 316 (M++1, 100%).
4m, white solid; mp 53-57 °C; 1H NMR (400 MHz, CDCl3)
7.23-7.29 (4 H, brm, ArH+NH), 7.10 (2 H, d, J 6.9, ArH), 5.10
(0.5 H, brs, NCH), 5.23 (0.5 H, brs, NCH), 3.27 (1 H, dd, J
13.9, 6.4, CH2), 3.18-3.19 (1 H, brm, CH2), 2.48 (2.5 H, s,
CH3), 2.27 (0.5 H, s, CH3), 1.36 (9 H, s, tBu); m/z (ES+) 304
(M++1, 100%). 4n, waxy solid; 1H NMR (400 MHz, CDCl3)
8.15 (1 H, brs, Indole 2-H), 7.40-7.45 (1 H, brm, ArH), 7.32-
7.36 (6 H, brm, ArH+amide NH), 7.17 (1 H, t, J 8.0, Indole 6-
H), 7.08 (1 H, t, J 7.4, Indole 5-H), 6.95 (1 H, brs, ArH), 5.39-
5.43 (1 H, brs NCH), 5.09-5.10 (2 H, m, OCH2), 3.42-3.43 (2
H, m, CH2), 2.40 (3 H, brs, CH3); m/z (ES+) 377 (M++1,
100%).
conditions with no conventional purification required.
The use of microwave technology clearly provided a prac-
tical advantage over thermal heating with the reaction
times being dramatically reduced. An alternative proce-
dure, using tosyl chloride and P-BEMP, was also success-
ful under similar conditions to provide 1,3,4-oxadiazoles
with comparable yields and purities.
References and Notes
(1) Collins, I. J. Chem. Soc., Perkin Trans. 1 2000, 2845-2861.
(2) For a comprehensive review see: Ley, S.V.; Baxendale, I.R.;
Bream, R.N.; Jackson, P.S.; Leach, A.G.; Longbottom, D.A.;
Nesi, M.; Scott, J.S.; Storer, R.I.; Taylor, S.J. J. Chem. Soc.,
Perkin Trans. 1 2000, 3815-4195.
(3) (a) Ladduwahetty, T.; Baker, R.; Cascieri, M.A.; Chambers,
M.S.; Haworth, K.; Keown, L.E.; MacIntyre, D.E.; Metzger,
J.M.; Owen, S.; Rycroft, W.; Sadowski, S.; Seward, E.M.;
Shepheard, S.L.; Swain, C.J.; Tattersall, F.D.; Watt, A.P.;
Williamson, D.W.; Hargreaves, R.J. J. Med. Chem. 1996, 39,
2907-2914; (b) Tully, W.G.; Gardner, C.R.; Gillespie, R.J.;
Westwood, W. J. Med. Chem. 1991, 34, 2060-2067; (c)
Swain, C.J.; Baker, R.; Kneen, C.; Saunders, J.; Seward, E.M.;
Stevenson, G.S.; Beer, M.; Stanton, J.; Watling, K. J. Med.
Chem. 1991, 34, 140-151; (d) Saunders, J.; Cassidy, M.;
Freedman, S.; Harley, E.A.; Iverson, L.L.; Kneen, C.;
Macleod, A.; Merchan, K.; Snow, R.J.; Baker, R. J. Med.
Chem. 1990, 33, 1128-1138.
(4) (a) Isobe, T.; Ishikawa, T. J. Org. Chem. 1999, 64, 6989; (b)
Lutun, S.; Hasaik, B.; Couturier, D. Synth. Commun. 1999,
29, 111; (c) Brown, B.J.; Clemens, I.R.; Neesom, J.K. Synlett
2000, 1, 131-133.
(5) Brain, C.T.; Paul, J.M.; Loong, Y.; Oakley, P.J. Tetrahedron
Lett. 1999, 40, 3275-3278.
(12) Procedure similar to reference (11) (1.1 eq of TsCl and 2 eq of
5 were required). The crude reaction mixture was shaken with
a large excess of Amberlyst 15for 10 min, filtered and shaken
with 5 eq of PS-carbonate (Argonaut Technologies) for 1 h.
The product was obtained after filtration of the resin and
evaporation of THF in vacuo. No further purification was
required.
(13) P-TsCl (1.45 mmol/g) was purchased from Argonaut Tech-
nologies.
(14) P-TBD (2.6 mmol/g) and P-BEMP (2.2 mmol/g) were
purchased from Fluka.
(15) (a) General procedure under thermal conditions: A mixture of
3 (0.1 mmol), tosyl chloride (1.2 eq) and P-BEMP (5 eq) in
THF was heated under reflux in a pre-heated oil bath for 4 h.
The reaction mixture was filtered and the THF was removed
in vacuo to give the oxadiazole 4, which required no further
purification; (b) General Procedure under microwave
conditions: To a solution of 3 (0.1 mmol) in THF (3 ml) was
added tosyl chloride (1.2 eq) and P-BEMP (5 eq). The reaction
mixture was irradiated for 5 × 1 min (100 W).11 After cooling
to room temperature in the microwave cavity, the reaction
mixture was filtered and the THF was removed in vacuo to
give 4, which required no further purification.
(6) Wipf, P.; Venkatraman, S.; Tetrahedron Lett. 1996, 37, 4659-
4662.
(7) General Procedure: Hydroxymethyl polystyrene resin (5 g,
Novabiochem, 0.87 mmol/g) was allowed to swell in the
minimum volume of dichloromethane with shaking.
Chlorosulfonyl isocyanate (20 eq) was added dropwise at RT
and the resulting mixture was shaken for 18 h. The resin was
filtered and washed with dichloromethane. The resin was
suspended in dichloromethane and the amine (20 eq) was
added at RT. The mixture was shaken for 18 h, after which
time the resin was filtered, washed with dichloromethane and
dried under high vacuum to give pale yellow beads. Elemental
analysis. 1. Found: S, 2.29%. Required: S, 2.37%; 2. Found:
S, 2.46%. Required: S, 2.32%.
(8) Wipf was unsuccessful in attaching Burgess reagent to a
modified Merrifield resin.6
(9) The reaction does not proceed in the presence of 5 alone.
(10) Amberlyst® 15 was purchased from Acros and washed
thoroughly with methanol before use.
(11) (a) General procedure under thermal conditions: A mixture of
3 (0.1 mmol), 2 (5 eq) and 5 (2 eq) in THF (3 ml) was heated
under reflux in a pre-heated oil bath for 4 h. The reaction
mixture was filtered and shaken with Amberlyst® 15 (excess)
Article Identifier:
1437-2096,E;2001,0,03,0382,0384,ftx,en;L22800ST.pdf
Synlett 2001, No. 3, 382–384 ISSN 0936-5214 © Thieme Stuttgart · New York